AstraZeneca-Merck’s Lynparza wins EU approval for pancreatic cancer
The approval was based on results from a late-stage trial in which Lynparza nearly doubled the lifespan of patients
AstraZeneca…
Recover your password.
A password will be e-mailed to you.